[Selection of Chemotherapy Regimen on the Basis of Monitoring NLR and Soluble PD-L1 during CRC Chemotherapy].Katsuki Muneoka, Makoto Miyazaki, Masataka Sasaki et al.|PubMed|2018Cited by 2